Rapid Improvement of Canine Cognitive Dysfunction with Immunotherapy designed for Alzheimer’s Disease

E-ISSN： 1875-5828|10|5|482-493

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.10, Iss.5, 2013-06, pp. : 482-493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alzheimer’s Disease—A Dysfunction in Cholesterol and Lipid Metabolism

By Lukiw Walter Pappolla Miguel Pelaez Ricardo Bazan Nicolas

Cellular and Molecular Neurobiology, Vol. 25, Iss. 3-4, 2005-06 ,pp. : 475-483

Springer Publishing Company

Access to resources Recommend Favorite

MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER’S DISEASE

By Snowden J. S.

Brain, Vol. 127, Iss. 1, 2004-01 ,pp. : 231-233

Oxford University Press

Access to resources Recommend Favorite

Platelet phospholipase A₂ activity in Alzheimer’s disease and mild cognitive impairment

By Gattaz W. F. Forlenza O. V. Talib L. L. Barbosa N. R. Bottino C. M. C.

Journal of Neural Transmission, Vol. 111, Iss. 5, 2004-05 ,pp. : 591-601

Springer Publishing Company

Access to resources Recommend Favorite

Cognitive deterioration in Alzheimer’s disease: is the early course predictive of the later stages?

By Capitani E. Cazzaniga R. Francescani A. Spinnler H.

Neurological Sciences, Vol. 25, Iss. 4, 2004-10 ,pp. : 198-204

Springer Publishing Company

Access to resources Recommend Favorite

Comparing regional brain atrophy in mild cognitive impairment and Alzheimer’s disease

By Weiler Marina Cendes Fernando Balthazar Marcio LF

Neurodegenerative Disease Management, Vol. 3, Iss. 5, 2013-10 ,pp. : 417-426

Future Medicine

Access to resources Recommend Favorite